Benjamin J. Hickey

2018

In 2018, Benjamin J. Hickey earned a total compensation of $3.5M as Senior Vice President and Chief Commercial Officer at Halozyme Therapeutics.

Compensation breakdown

Bonus$180,000
Non-Equity Incentive Plan$86,160
Option Awards$1,500,004
Salary$145,313
Stock Awards$1,500,009
Other$91,485
Total$3,502,971

Hickey received $1.5M in stock awards, accounting for 43% of the total pay in 2018.

Hickey also received $180K in bonus, $86.2K in non-equity incentive plan, $1.5M in option awards, $145.3K in salary and $91.5K in other compensation.

Rankings

In 2018, Benjamin J. Hickey's compensation ranked 3,245th out of 14,244 executives tracked by ExecPay. In other words, Hickey earned more than 77.2% of executives.

ClassificationRankingPercentile
All
3,245
out of 14,244
77th
Division
Manufacturing
1,203
out of 5,765
79th
Major group
Chemicals And Allied Products
417
out of 2,128
80th
Industry group
Drugs
345
out of 1,817
81st
Industry
Biological Products, Except Diagnostic Substances
75
out of 339
78th

Pay ratio

Benjamin J. Hickey's Pay$3,502,971
Median Employee's Pay$199,899
Pay Ratio

18

to 1

In 2018, the annual total compensation of Benjamin J. Hickey was $3,502,971.

The annual total compensation of the median employee at Halozyme Therapeutics was $199,899.

The ratio of Benjamin J. Hickey's pay to the pay of median employee was therefore 18 to one.

Source: SEC filing on March 22, 2019.

Hickey's colleagues

We found four more compensation records of executives who worked with Benjamin J. Hickey at Halozyme Therapeutics in 2018.

2018

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2018

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

2018

Harry Leonhardt

Halozyme Therapeutics

General Counsel

2018

Dimitrios Chondros

Halozyme Therapeutics

Chief Medical Officer

News

You may also like